IDH1 and central nervous system cancer: The median OS for patients with IDH mutant gliomas who harbored these CNAs was 65 months, whereas the median OS for all others could not be defined (hazard ratio = 0.255; 95% CI: 0.111–0.586; p < 0.0001).